Today's Spotlight

Glaucoma’s New Foe, Explained

A 73-year-old woman presented for her glaucoma progress evaluation. She had been diagnosed with primary open-angle glaucoma (OAG) four years earlier and started on latanoprost 0.005% in each eye, which she tolerated well. She was 20/25 OU and her vision was commensurate with her mild cataracts.

Her visual fields showed very mild loss OD and a moderately extensive inferior arcuate defect OS. Recent visual field analysis confirmed no changes in either eye. Central corneal thickness was 562µm OD and 568µm OS. Intraocular pressures (IOPs) were 19mm Hg OU. Her best IOP reduction from latanoprost was 15mm Hg OD and 17mm Hg OS.
Today's Spotlight

Foretold in the Stars

A 54-year-old Hispanic male presented with complaints of blurred vision in his right eye for the past month. The patient has never had eye problems in the past and has always enjoyed good vision.

Find our more about this case in our most recent Retina Quiz.
Today's Spotlight

Don’t Stress

Q: What is the real significance of endothelial blebs and how do I best view them in my scleral lens wearers?

Find out in our most recent Cornea + Contact Lens Q + A.
Today's Spotlight

Look Out for Iatrogenic Dry Eye

A notable addition to TFOS DEWS II is a report on iatrogenic dry eye. Not a subject covered in the original DEWS report, it was time to acknowledge “the number of cases of dry eye that are caused by medical examination or treatment such as topical medications, systemic drugs, ophthalmic surgical procedures and even cosmetic procedures,” says James S. Wolffsohn, PhD, a member of the DEWS II iatrogenic subcommittee and harmonizer for the report. This article discusses the new findings in iatrogenic dry eye and how you can use them to better serve your patients.
Today's Spotlight

Breaking the Burden: A New Way to Deliver Anti-VEGF

Anti-vascular endothelial growth factor (VEGF) therapy has dramatically revolutionized the management of age-related macular degeneration (AMD), diabetic macular edema and retinal vein occlusions. Many trials have shown that, worldwide, the treatment has significantly changed outcomes in patients with retinal vascular disease and reduced the incidence of blindness from these conditions. In each of these indications, the best outcomes have been shown with fixed dosing schedules. However, such a regimen risks either over- or undertreatment if the chosen intervals between treatments are too short or too long.

New technologies that could extend the duration between treatments could offer a significant benefit to patients by reducing the burden of treatment while improving vision. 
Feb 25
Feb 24
Feb 23
Feb 22
Feb 21

Look Inside The Current Issue

February 15, 2018

Features

AI for DR: “The Digital Doctor Will See You Now”

Software that can detect ocular anomalies may offer new ways to reduce the loss of vision due to diabetic retinopathy.

Breaking the Burden: A New Way to Deliver Anti-VEGF

An implantable drug reservoir looks to shake up today’s successful but untenable protocols.

How the Diploma Deluge is Reshaping Optometry

The student population is booming, but applicants haven’t kept pace. Here are three ways to protect academic standards and avoid a glut.

Myopia Management in Action

These clinical pearls can help you establish a successful subspecialty within your practice.

Prospects for Neuroprotection in Glaucoma

Investigators are gunning for glaucoma. Here, one shares some thoughts from the frontlines.

Rethinking Endothelial Repair

An eye drop that might regrow cells and a graft-free surgical technique may soon revolutionize the treatment regimen for these patients.

Thyroid Disease: A Delicate Balance Disrupted

This diagnosis isn’t as cut-and-dry as you think; be prepared to manage both hyper- and hypothyroid patients.

Departments

25 Ways to Win the Temp Wars

Private practice optometry runs hot and cold—and I’m not talking about the business side of things.

A Bad Break-up

When the vitreous and retina don’t separate fully, macular traction can be problematic—or benign. How, and when, to manage?

A Giant Problem Overlooked

Don’t always attribute new patient complaints to age—especially if it could be giant cell arteritis.

Don’t Stress

Endothelial blebs be a sign of a problematic scleral lens fit. Here’s what you should do to avoid them.

Foretold in the Stars

How do this patient’s comorbidities inform your diagnosis?

Glaucoma’s New Foe, Explained

How a recently approved formulation aims to improve pressure control.

Hone Your Astigmatic Refraction

Use these tips to refine your skills and perform this task more swiftly.

Letters to the Editor

"We must, as a profession, start speaking about low vision to all AMD patients."

Lumps and Bumps Be Gone

Shave excision can be a simple answer to your patient’s eyelid margin lesion.

News Review

Precision Eye Care | AMD | 2018 Conference Schedule

Product Review

Contact Lenses | Diagnostic Technology

Reinventing Optometry Every Day

One thing we can count on is continuous, rapid change—and our profession is no exception.

She’s on a Losing Streak

A 52-year-old white female presented to the office with a chief complaint of blurry vision in both eyes at distance and near.

The Coding is in the Details

Using new technologies to screen for early disease can be great for patient care—as long as you use them wisely.

The Stars of Tomorrow

We shine a light on several new ideas that might change clinical practice. Will they flourish—or flop?

Two Conditions, One Implant

Non-medical options may be more appropriate when glaucoma patients also have ocular surface disease.

Where’s the Degeneration?

A significant case of subretinal hemorrhaging leads one OD to a rare disease.

E-Newsletters

Practice Pearls

Expert clinician Paul Karpecki, OD, provides practical insights and management strategies for a wide array of ocular conditions.

RCCL e-News

A quick read of the best pearls from the current issue of Review of Cornea & Contact Lenses, with links to full articles.

Optometric Retina Society E-Newsletter

Keep up to date on the latest research and clinical findings in retinal disease care with this quarterly publication from the ORS.

Optometric Physician E-Journal

A weekly e-journal edited by Art Epstein, OD, featuring incisive commentary, timely research summaries and late-breaking news.

Jobs

Jobs Powered By Local Eye Site

Review of Cornea & Contact Lenses

Jan/Feb 2018

Women in Optometry

Women in Optometry - November 2017